Cargando…

Bone matrix development in steroid-induced osteoporosis is associated with a consistently reduced fibrillar stiffness linked to altered bone mineral quality

Glucocorticoid-induced osteoporosis (GIOP) is a major secondary form of osteoporosis, with the fracture risk significantly elevated – at similar levels of bone mineral density – in patients taking glucocorticoids compared with non-users. The adverse bone structural changes at multiple hierarchical l...

Descripción completa

Detalles Bibliográficos
Autores principales: Xi, L., De Falco, P., Barbieri, E., Karunaratne, A., Bentley, L., Esapa, C.T., Terrill, N.J., Brown, S.D.M., Cox, R.D., Davis, G.R., Pugno, N.M., Thakker, R.V., Gupta, H.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084282/
https://www.ncbi.nlm.nih.gov/pubmed/29902593
http://dx.doi.org/10.1016/j.actbio.2018.05.053
_version_ 1783346145588674560
author Xi, L.
De Falco, P.
Barbieri, E.
Karunaratne, A.
Bentley, L.
Esapa, C.T.
Terrill, N.J.
Brown, S.D.M.
Cox, R.D.
Davis, G.R.
Pugno, N.M.
Thakker, R.V.
Gupta, H.S.
author_facet Xi, L.
De Falco, P.
Barbieri, E.
Karunaratne, A.
Bentley, L.
Esapa, C.T.
Terrill, N.J.
Brown, S.D.M.
Cox, R.D.
Davis, G.R.
Pugno, N.M.
Thakker, R.V.
Gupta, H.S.
author_sort Xi, L.
collection PubMed
description Glucocorticoid-induced osteoporosis (GIOP) is a major secondary form of osteoporosis, with the fracture risk significantly elevated – at similar levels of bone mineral density – in patients taking glucocorticoids compared with non-users. The adverse bone structural changes at multiple hierarchical levels in GIOP, and their mechanistic consequences leading to reduced load-bearing capacity, are not clearly understood. Here we combine experimental X-ray nanoscale mechanical imaging with analytical modelling of the bone matrix mechanics to determine mechanisms causing bone material quality deterioration during development of GIOP. In situ synchrotron small-angle X-ray diffraction combined with tensile testing was used to measure nanoscale deformation mechanisms in a murine model of GIOP, due to a corticotrophin-releasing hormone promoter mutation, at multiple ages (8-, 12-, 24- and 36 weeks), complemented by quantitative micro-computed tomography and backscattered electron imaging to determine mineral concentrations. We develop a two-level hierarchical model of the bone matrix (mineralized fibril and lamella) to predict fibrillar mechanical response as a function of architectural parameters of the mineralized matrix. The fibrillar elastic modulus of GIOP-bone is lower than healthy bone throughout development, and nearly constant in time, in contrast to the progressively increasing stiffness in healthy bone. The lower mineral platelet aspect ratio value for GIOP compared to healthy bone in the multiscale model can explain the fibrillar deformation. Consistent with this result, independent measurement of mineral platelet lengths from wide-angle X-ray diffraction finds a shorter mineral platelet length in GIOP. Our results show how lowered mineralization combined with altered mineral nanostructure in GIOP leads to lowered mechanical competence. SIGNIFICANCE STATEMENT: Increased fragility in musculoskeletal disorders like osteoporosis are believed to arise due to alterations in bone structure at multiple length-scales from the organ down to the supramolecular-level, where collagen molecules and elongated mineral nanoparticles form stiff fibrils. However, the nature of these molecular-level alterations are not known. Here we used X-ray scattering to determine both how bone fibrils deform in secondary osteoporosis, as well as how the fibril orientation and mineral nanoparticle structure changes. We found that osteoporotic fibrils become less stiff both because the mineral nanoparticles became shorter and less efficient at transferring load from collagen, and because the fibrils are more randomly oriented. These results will help in the design of new composite musculoskeletal implants for bone repair.
format Online
Article
Text
id pubmed-6084282
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-60842822018-08-10 Bone matrix development in steroid-induced osteoporosis is associated with a consistently reduced fibrillar stiffness linked to altered bone mineral quality Xi, L. De Falco, P. Barbieri, E. Karunaratne, A. Bentley, L. Esapa, C.T. Terrill, N.J. Brown, S.D.M. Cox, R.D. Davis, G.R. Pugno, N.M. Thakker, R.V. Gupta, H.S. Acta Biomater Article Glucocorticoid-induced osteoporosis (GIOP) is a major secondary form of osteoporosis, with the fracture risk significantly elevated – at similar levels of bone mineral density – in patients taking glucocorticoids compared with non-users. The adverse bone structural changes at multiple hierarchical levels in GIOP, and their mechanistic consequences leading to reduced load-bearing capacity, are not clearly understood. Here we combine experimental X-ray nanoscale mechanical imaging with analytical modelling of the bone matrix mechanics to determine mechanisms causing bone material quality deterioration during development of GIOP. In situ synchrotron small-angle X-ray diffraction combined with tensile testing was used to measure nanoscale deformation mechanisms in a murine model of GIOP, due to a corticotrophin-releasing hormone promoter mutation, at multiple ages (8-, 12-, 24- and 36 weeks), complemented by quantitative micro-computed tomography and backscattered electron imaging to determine mineral concentrations. We develop a two-level hierarchical model of the bone matrix (mineralized fibril and lamella) to predict fibrillar mechanical response as a function of architectural parameters of the mineralized matrix. The fibrillar elastic modulus of GIOP-bone is lower than healthy bone throughout development, and nearly constant in time, in contrast to the progressively increasing stiffness in healthy bone. The lower mineral platelet aspect ratio value for GIOP compared to healthy bone in the multiscale model can explain the fibrillar deformation. Consistent with this result, independent measurement of mineral platelet lengths from wide-angle X-ray diffraction finds a shorter mineral platelet length in GIOP. Our results show how lowered mineralization combined with altered mineral nanostructure in GIOP leads to lowered mechanical competence. SIGNIFICANCE STATEMENT: Increased fragility in musculoskeletal disorders like osteoporosis are believed to arise due to alterations in bone structure at multiple length-scales from the organ down to the supramolecular-level, where collagen molecules and elongated mineral nanoparticles form stiff fibrils. However, the nature of these molecular-level alterations are not known. Here we used X-ray scattering to determine both how bone fibrils deform in secondary osteoporosis, as well as how the fibril orientation and mineral nanoparticle structure changes. We found that osteoporotic fibrils become less stiff both because the mineral nanoparticles became shorter and less efficient at transferring load from collagen, and because the fibrils are more randomly oriented. These results will help in the design of new composite musculoskeletal implants for bone repair. Elsevier 2018-08 /pmc/articles/PMC6084282/ /pubmed/29902593 http://dx.doi.org/10.1016/j.actbio.2018.05.053 Text en © 2018 Elsevier Ltd. All rights reserved. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Xi, L.
De Falco, P.
Barbieri, E.
Karunaratne, A.
Bentley, L.
Esapa, C.T.
Terrill, N.J.
Brown, S.D.M.
Cox, R.D.
Davis, G.R.
Pugno, N.M.
Thakker, R.V.
Gupta, H.S.
Bone matrix development in steroid-induced osteoporosis is associated with a consistently reduced fibrillar stiffness linked to altered bone mineral quality
title Bone matrix development in steroid-induced osteoporosis is associated with a consistently reduced fibrillar stiffness linked to altered bone mineral quality
title_full Bone matrix development in steroid-induced osteoporosis is associated with a consistently reduced fibrillar stiffness linked to altered bone mineral quality
title_fullStr Bone matrix development in steroid-induced osteoporosis is associated with a consistently reduced fibrillar stiffness linked to altered bone mineral quality
title_full_unstemmed Bone matrix development in steroid-induced osteoporosis is associated with a consistently reduced fibrillar stiffness linked to altered bone mineral quality
title_short Bone matrix development in steroid-induced osteoporosis is associated with a consistently reduced fibrillar stiffness linked to altered bone mineral quality
title_sort bone matrix development in steroid-induced osteoporosis is associated with a consistently reduced fibrillar stiffness linked to altered bone mineral quality
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084282/
https://www.ncbi.nlm.nih.gov/pubmed/29902593
http://dx.doi.org/10.1016/j.actbio.2018.05.053
work_keys_str_mv AT xil bonematrixdevelopmentinsteroidinducedosteoporosisisassociatedwithaconsistentlyreducedfibrillarstiffnesslinkedtoalteredbonemineralquality
AT defalcop bonematrixdevelopmentinsteroidinducedosteoporosisisassociatedwithaconsistentlyreducedfibrillarstiffnesslinkedtoalteredbonemineralquality
AT barbierie bonematrixdevelopmentinsteroidinducedosteoporosisisassociatedwithaconsistentlyreducedfibrillarstiffnesslinkedtoalteredbonemineralquality
AT karunaratnea bonematrixdevelopmentinsteroidinducedosteoporosisisassociatedwithaconsistentlyreducedfibrillarstiffnesslinkedtoalteredbonemineralquality
AT bentleyl bonematrixdevelopmentinsteroidinducedosteoporosisisassociatedwithaconsistentlyreducedfibrillarstiffnesslinkedtoalteredbonemineralquality
AT esapact bonematrixdevelopmentinsteroidinducedosteoporosisisassociatedwithaconsistentlyreducedfibrillarstiffnesslinkedtoalteredbonemineralquality
AT terrillnj bonematrixdevelopmentinsteroidinducedosteoporosisisassociatedwithaconsistentlyreducedfibrillarstiffnesslinkedtoalteredbonemineralquality
AT brownsdm bonematrixdevelopmentinsteroidinducedosteoporosisisassociatedwithaconsistentlyreducedfibrillarstiffnesslinkedtoalteredbonemineralquality
AT coxrd bonematrixdevelopmentinsteroidinducedosteoporosisisassociatedwithaconsistentlyreducedfibrillarstiffnesslinkedtoalteredbonemineralquality
AT davisgr bonematrixdevelopmentinsteroidinducedosteoporosisisassociatedwithaconsistentlyreducedfibrillarstiffnesslinkedtoalteredbonemineralquality
AT pugnonm bonematrixdevelopmentinsteroidinducedosteoporosisisassociatedwithaconsistentlyreducedfibrillarstiffnesslinkedtoalteredbonemineralquality
AT thakkerrv bonematrixdevelopmentinsteroidinducedosteoporosisisassociatedwithaconsistentlyreducedfibrillarstiffnesslinkedtoalteredbonemineralquality
AT guptahs bonematrixdevelopmentinsteroidinducedosteoporosisisassociatedwithaconsistentlyreducedfibrillarstiffnesslinkedtoalteredbonemineralquality